Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with tailor made ADME-Tox research services.
The service offering is widely spread over the whole ADME-Tox area. Admescope’s top-notch expertise lies in in vitro & in vivo drug metabolism; including metabolite profiling & identification, drug-drug interactions, early pharmacokinetics and quantitative bioanalysis. The right assays are always available, whether in the discovery, lead optimisation or preclinical development phase. The level of data interpretation can also be customised according to customer preferences.
In addition to small molecules and peptides Admescope provides services also for large molecules.
Currently Admescope serves customers in 29 countries on four continents. To learn more, please visit www.admescope.com.